Misled by a false sense of security?
The pandemic of the vaccinated.
Official British data recently published:
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027511/Vaccine-surveillance-report-week-42.pdf
The pandemic of the vaccinated.
Official British data recently published:
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027511/Vaccine-surveillance-report-week-42.pdf
Atovaquone joins a long list of antimalarials that show antiviral activity against SARS-CoV-2 in vitro.
https://pubs.acs.org/doi/abs/10.1021/acsinfecdis.1c00278
https://pubs.acs.org/doi/abs/10.1021/acsinfecdis.1c00278
ACS Publications
Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern
The antimicrobial medication malarone (atovaquone/proguanil) is used as a fixed-dose combination for treating children and adults with uncomplicated malaria or as chemoprophylaxis for preventing malaria in travelers. It is an inexpensive, efficacious, and…
OSINT
Discussion of Glutamine deficiency and COVID-19 https://www.nature.com/articles/s41418-021-00892-y
Eye-popping results from Glutamine supplementation in small prospective controlled study (n=54) of hospitalized Covid patients from Azerbaijan.
https://www.researchsquare.com/article/rs-748690/v1
https://www.researchsquare.com/article/rs-748690/v1
OSINT
Eye-popping results from Glutamine supplementation in small prospective controlled study (n=54) of hospitalized Covid patients from Azerbaijan. https://www.researchsquare.com/article/rs-748690/v1
Those results are consistent with those from a similar Afghan Glutamine study (n=60).
https://www.sciencedirect.com/science/article/pii/S2352939320300166
https://www.sciencedirect.com/science/article/pii/S2352939320300166
A small discussion of the possible antioxidant mechanism of action of Glutamine in this paper:
https://clinmedjournals.org/articles/jide/journal-of-infectious-diseases-and-epidemiology-jide-7-187.php?jid=jide
https://clinmedjournals.org/articles/jide/journal-of-infectious-diseases-and-epidemiology-jide-7-187.php?jid=jide
www.clinmedjournals.org
Overview of the Rationale for L-Glutamine Treatment in Moderate-Severe COVID-19 Infection
This overview focuses on how to overcome the treatment challenges posed by COVID-19 infection and reduce mortality with antioxidant therapy. The rationale for this treatment approach is explored by addressing the following objectives
OSINT
A small discussion of the possible antioxidant mechanism of action of Glutamine in this paper: https://clinmedjournals.org/articles/jide/journal-of-infectious-diseases-and-epidemiology-jide-7-187.php?jid=jide
Is Glutamine depletion a big issue in COVID-19?
This paper discusses the evidence of downregulation.
https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26716
This paper discusses the evidence of downregulation.
https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26716
Wiley Online Library
Understanding the pathophysiological changes via untargeted metabolomics in COVID‐19 patients
Coronavirus disease 2019 (COVID-19) is an infectious respiratory disease caused by a new strain of the coronavirus. There is limited data on the pathogenesis and the cellular responses of COVID-19. I...
"Sucking an iota-carrageenan containing lozenge releases sufficient iota-carrageenan to neutralize and inactivate the most abundant respiratory viruses as well as pandemic SARS-CoV-2."
https://www.dovepress.com/articles.php?article_id=68558
https://www.dovepress.com/articles.php?article_id=68558
Dovepress
Iota-Carrageenan Containing Lozenges for Colds and COVID-19 | IJGM
Investigating whether iota-carrageenan lozenges can neutralize viral binding and replication of common cold viruses and SARS-CoV-2 in healthy patients.
Media is too big
VIEW IN TELEGRAM
COVID-19: platelets, serotonin, SSRIs, and cyproheptadine
Management of platelet hyperactivation in COVID-19 is critical.
Here is an excellent presentation by Farid Jalali on the nasty blood disorder and the little discussed resulting serotonin syndrome.
With therapeutic solutions (SSRIs, cyproheptadine).
[source]
Management of platelet hyperactivation in COVID-19 is critical.
Here is an excellent presentation by Farid Jalali on the nasty blood disorder and the little discussed resulting serotonin syndrome.
With therapeutic solutions (SSRIs, cyproheptadine).
[source]
Media is too big
VIEW IN TELEGRAM
PCR: Positive Count Rising
Basics of the PCR technique as it applies to COVID-19, featuring insights from the late Kary Mullis.
note: see comment section for additional resources
Basics of the PCR technique as it applies to COVID-19, featuring insights from the late Kary Mullis.
note: see comment section for additional resources
Media is too big
VIEW IN TELEGRAM
The COVID Media
An examination of mainstream media coverage of COVID-19.
An examination of mainstream media coverage of COVID-19.
Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7645850/
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7645850/
PubMed Central (PMC)
Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease
Patient comprehension is a critical part of meeting medical ethics standards of informed consent in study designs. The aim of the study was to determine if sufficient literature exists to require clinicians to disclose the specific risk that COVID‐19 ...
This media is not supported in your browser
VIEW IN TELEGRAM
How to Use CDC's Wonder System
Generate custom reports using the VAERS database, with CDC's Wonder system, and find out which adverse events are right for you =)
Generate custom reports using the VAERS database, with CDC's Wonder system, and find out which adverse events are right for you =)
This media is not supported in your browser
VIEW IN TELEGRAM
Gain-of-Function
Some background on gain-of-function research as it relates to the timeline of pandemic response simulations from 2010 to present.
Some background on gain-of-function research as it relates to the timeline of pandemic response simulations from 2010 to present.